FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin

Print this page INCHEON, KOREA – January 21, 2019 – Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Ontruzant (trastuzumab-dttb), a biosimilar referencing Herceptin®i (trastuzumab), across all eligible indications, namely adjuvant treatment of HER2-overexpressing breast cancer, metastatic breast cancer and metastatic gastric cancer or gastroesophageal junction adenocarcinoma… Read More: FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin »

High-fat diet 'increases risks of food poisoning and infectious disease'

It can live and grow in a wide range of foods, in particular chilled ready-to-eat foods such as packaged sandwiches, butter, cooked sliced meats, smoked salmon, certain soft cheeses and pate. High-fat diet ‘increases risks of food poisoning and infectious disease’ Independent.ie A high-fat “western” diet weakens the ability of the immune system to fight… Read More: High-fat diet 'increases risks of food poisoning and infectious disease' »